BIOMAT Database Logo BIOMAT Database Logo

[The treatment of acute leukemia in children during remission]. 1967

F M Reznichenko

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015122 Mercaptopurine An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. 6-Mercaptopurine,1,7-Dihydro-6H-purine-6-thione,6-Mercaptopurine Monohydrate,6-Thiohypoxanthine,6-Thiopurine,6H-Purine-6-thione, 1,7-dihydro-,BW 57-323H,Leupurin,Mecaptopurine Anhydrous,Mercaptopurina Wellcome,Puri-Nethol,Purimethol,Purinethol,6 Mercaptopurine,6 Mercaptopurine Monohydrate,6 Thiohypoxanthine,6 Thiopurine,BW 57 323H,BW 57323H

Related Publications

F M Reznichenko
[Results of intensive treatment of children during the 1st remission of acute lymphoblastic leukemia].
January 1973, Polski tygodnik lekarski (Warsaw, Poland : 1960),
F M Reznichenko
[Infectious mononucleosis during remission in acute leukemia in 2 children].
April 1972, Polski tygodnik lekarski (Warsaw, Poland : 1960),
F M Reznichenko
[Herpesvirus infections during treatment inducing remission of acute leukemia].
October 1983, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
F M Reznichenko
[Active immunotherapy of children with acute leukemia during complete remission].
February 1975, Problemy gematologii i perelivaniia krovi,
F M Reznichenko
[PLASMO-LEUKO-THROMBOCYTAPHERESIS IN CHILDREN WITH ACUTE LEUKEMIA DURING THE REMISSION PERIOD].
February 1965, Problemy gematologii i perelivaniia krovi,
F M Reznichenko
[Electrolytic changes in children with acute lymphoblastic leukemia during remission induction].
June 1995, Sangre,
F M Reznichenko
Neuroblastoma during acute lymphoblastic leukemia in remission.
October 1988, Cancer,
F M Reznichenko
[Use of thymalin in the treatment of children with lymphoblastic leukemia during remission].
July 1986, Gematologiia i transfuziologiia,
F M Reznichenko
[Long-term remission of acute leukemia in children with different treatment schedules].
July 1976, Problemy gematologii i perelivaniia krovi,
F M Reznichenko
[Use of alpha interferon preparations in acute lymphoblastic leukemia in children during remission].
January 1991, Pediatriia,
Copied contents to your clipboard!